Meta Platforms
META
Alphabet-C
GOOG
Alphabet-A
GOOGL
Vale SA
VALE
Coinbase
COIN
US Stock MarketDetailed Quotes
ZYBT Zhengye Biotechnology
- 4.270
- -0.210-4.69%
Close Jan 24 16:00 ET
202.36MMarket Cap72.37P/E (TTM)
4.480High4.200Low47.26KVolume4.415Open4.480Pre Close205.68KTurnover2.74%Turnover Ratio46.41P/E (Static)47.39MShares6.10052wk High5.24P/B7.37MFloat Cap3.70052wk Low--Dividend TTM1.73MShs Float6.100Historical High--Div YieldTTM6.25%Amplitude3.700Historical Low4.351Avg Price1Lot Size
Zhengye Biotechnology Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|
| Operating Cash Flow (Indirect Method) | |||
| Cash flow from continuing operating activities | 177.96%48.18M | -45.50%17.34M | 31.81M |
| Net income from continuing operations | -32.71%37.51M | 19.96%55.74M | --46.47M |
| Operating gains losses | --187K | ---- | ---53K |
| Depreciation and amortization | 27.19%23.91M | 17.41%18.8M | --16.01M |
| Deferred tax | 169.29%758K | -205.59%-1.09M | ---358K |
| Other non cash items | ---- | ---- | --2K |
| Change In working capital | 69.33%-20.49M | -98.21%-66.82M | ---33.71M |
| -Change in receivables | 180.32%38.05M | -15.82%-47.38M | ---40.91M |
| -Change in inventory | -4.68%-12.9M | 0.15%-12.33M | ---12.34M |
| -Change in prepaid assets | 14.88%-618K | -180.31%-726K | ---259K |
| -Change in payables and accrued expense | -578.37%-44.09M | -134.89%-6.5M | --18.63M |
| -Change in other current liabilities | -6.86%-218K | 11.30%-204K | ---230K |
| -Change in other working capital | -325.55%-715K | -77.29%317K | --1.4M |
| Cash from discontinued investing activities | |||
| Operating cash flow | 177.96%48.18M | -45.50%17.34M | --31.81M |
| Investing cash flow | |||
| Cash flow from continuing investing activities | 56.95%-11.77M | -4.03%-27.33M | -26.27M |
| Net PPE purchase and sale | 76.81%-6.34M | -44.35%-27.33M | ---18.93M |
| Net intangibles purchase and sale | ---4.2M | --0 | ---7.34M |
| Net investment purchase and sale | ---1.22M | --0 | ---- |
| Cash from discontinued investing activities | |||
| Investing cash flow | 56.95%-11.77M | -4.03%-27.33M | ---26.27M |
| Financing cash flow | |||
| Cash flow from continuing financing activities | -241.06%-18.98M | 541.44%13.46M | -3.05M |
| Net issuance payments of debt | -28.41%24.97M | 336.00%34.88M | --8M |
| Cash dividends paid | -84.14%-39.45M | -93.93%-21.43M | ---11.05M |
| Net other financing activities | ---4.5M | ---- | ---- |
| Cash from discontinued financing activities | |||
| Financing cash flow | -241.06%-18.98M | 541.44%13.46M | ---3.05M |
| Net cash flow | |||
| Beginning cash position | 55.09%9.75M | 65.59%6.28M | --3.8M |
| Current changes in cash | 403.76%17.44M | 39.09%3.46M | --2.49M |
| End cash Position | 178.95%27.19M | 55.09%9.75M | --6.28M |
| Free cash flow | 466.10%36.58M | -284.75%-9.99M | --5.41M |
| Currency Unit | CNY | CNY | CNY |
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
